ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS · Delayed Price · Currency is USD
12.00
+0.91 (8.21%)
Oct 6, 2025, 1:14 PM EDT
ZIVO Bioscience Market Cap
ZIVO Bioscience has a market cap or net worth of $44.85 million as of October 7, 2025. Its market cap has increased by 100.01% in one year.
Market Cap
44.85M
Enterprise Value
45.62M
Revenue
174.90K
Ranking
n/a
PE Ratio
n/a
Stock Price
$12.00
Market Cap Chart
Since October 30, 2003, ZIVO Bioscience's market cap has increased from 2.41M to 44.85M, an increase of 1,758.43%. That is a compound annual growth rate of 14.25%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 3, 2025 | 44.85M | -41.18% |
Dec 31, 2024 | 76.25M | 3,046.50% |
Dec 29, 2023 | 2.42M | -89.71% |
Dec 30, 2022 | 23.55M | -12.89% |
Dec 31, 2021 | 27.03M | -56.08% |
Dec 31, 2020 | 61.55M | 6.15% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Veradigm | 798.20M |
Elite Pharmaceuticals | 686.89M |
Glass House Brands | 644.95M |
Northwest Biotherapeutics | 382.92M |
Nika Pharmaceuticals | 333.67M |
CytoDyn | 326.79M |
American Oncology Network | 281.53M |
Silence Therapeutics | 236.17M |